Aortic sarcoma is a rare entity. In this study, we report a case of a 56-year-old man with complaints of pain and numbness of bilateral lower extremities. An endovascular aortic repair was finally adopted to prevent recurrent embolic events. An endo-biopsy was performed and showed aortic sarcoma. Axillary bifemoral and femoro-femoral cross-over bypass surgeries were taken to supply blood to the lower extremities in the 6th month after the first operation. He finally passed away in the 37th month. Aortic sarcoma should be taken into consideration as one of the possible etiologies for massive thrombus in aorta. Palliative surgeries such as bypass, endovascular aortic repair can also be an alternative to treat aortic sarcoma.
14 March 2022 in Journal of International Medical Research
Objective: Atherosclerosis (AS) is a life-threatening disease in aging populations worldwide. However, the molecular and gene regulation mechanisms of AS are still unclear. This study aimed to identify gene expression differences between atheroma plaques and normal tissues in humans. Methods: The expression profiling dataset GSE43292 was obtained from the Gene Expression Omnibus (GEO) dataset. The differentially expressed genes (DEGs) were identified between the atheroma plaques and normal tissues via GEO2R, and functional annotation of the DEGs was performed by GSEA. STRING and MCODE plug-in of Cytoscape were used to construct a protein–protein interaction (PPI) network and analyze hub genes. Finally, quantitative polymerase chain reaction (qPCR) was performed to verify the hub genes. Results: Overall, 134 DEGs were screened. Functional annotation demonstrated that these DEGs were mainly enriched in sphingolipid metabolism, apoptosis, lysosome, and more. Six hub genes were identified from the PPI network: ITGAX, CCR1, IL1RN, CXCL10, CD163, and MMP9. qPCR analysis suggested that the relative expression levels of the six hub genes were significantly higher in AS samples. Conclusions: We used bioinformatics to identify six hub genes: ITGAX, CCR1, IL1RN, CXCL10, CD163, and MMP9. These hub genes are potential promising diagnostic and therapeutic targets for AS.